Fundz

Who to call at Pathos AI, and when

Fundz watches for the moments Pathos AI starts buying, and tells you who to reach.

  • An alert the day Pathos AI raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Pathos AI, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Pathos AI. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Pathos AI and AstraZeneca Enter Co-Exclusive Licensing Agreement for AZD4241 in ER+ Breast Cancer Research.

Aug 04, 2026

Contract Type

agreement

ChicagoBiotechnologyHealth CareArtificial IntelligenceTherapeuticsMachine LearningPharmaceuticalHealth Diagnostics

Description

Pathos AI has announced a collaboration and co-exclusive licensing agreement with AstraZeneca to advance AZD4241, an investigational therapy for ER+/HER2- breast cancer. Pathos will lead the early clinical development, leveraging its AI-driven Foundry platform to optimize trial design and patient stratification.

Company Information

Company

Pathos AI

Location

600 W. CHICAGO AVE.

Chicago, Illinois, United States

About

Pathos is an AI-enabled biotechnology company focused on re-engineering drug development, leveraging the power of technology to bring precision medicine to patients through partnerships with pharmaceutical companies. Pathos has raised over $100 million to accelerate the development of precision medicines and to expand its platform, combining computational approaches across multimodal real-world data and patient-derived biological models.

Related People

Ryan
Likely contact at this company
••••••••@••••••••

See Ryan's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Pathos AI's next move

Learn about Strategic plan

Pathos AI signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.